Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mendelian randomization study of the effect of coronary artery calcification on atherosclerotic cardiovascular diseases. | Sci Rep | 2022 | 36050433 | PubTator, text mining | PubMed |
| The TRESLIN-MTBP complex couples completion of DNA replication with S/G2 transition. | Mol Cell | 2022 | 36049481 | PubTator, text mining | PubMed |
| Adaptive exchange sustains cullin-RING ubiquitin ligase networks and proper licensing of DNA replication. | Proc Natl Acad Sci U S A | 2022 | 36037385 | PubTator, text mining | PubMed |
| Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway. | Biomedicines | 2022 | 36009559 | PubTator, text mining | PubMed |
| The Role of Hsp90-R2TP in Macromolecular Complex Assembly and Stabilization. | Biomolecules | 2022 | 36008939 | PubTator, text mining | PubMed |
| Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. | Cancer Discov | 2022 | 36001024 | PubTator, text mining | PubMed |
| Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems. | Bioimpacts | 2022 | 35975201 | PubTator, text mining | PubMed |
| Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers. | Clin Cancer Res | 2022 | 35972731 | PubTator, text mining | PubMed |
| Mesenchymal Stem/Stromal Cells May Decrease Success of Cancer Treatment by Inducing Resistance to Chemotherapy in Cancer Cells. | Cancers (Basel) | 2022 | 35954425 | PubTator, text mining | PubMed |
| Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth. | iScience | 2022 | 35942091 | PubTator, text mining | PubMed |
| Single-atom logic for heterocycle editing. | Nat Synth | 2022 | 35935106 | PubTator, text mining | PubMed |
| Identification of target and pathway of aspirin combined with Lipitor treatment in prostate cancer through integrated bioinformatics analysis. | Toxicol Appl Pharmacol | 2022 | 35926565 | PubTator, text mining | PubMed |
| Moonlighting at the Poles: Non-Canonical Functions of Centrosomes. | Front Cell Dev Biol | 2022 | 35912107 | PubTator, text mining | PubMed |
| Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence. | Stem Cells Int | 2022 | 35910534 | PubTator, text mining | PubMed |
| Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1. | Hum Genomics | 2022 | 35906672 | PubTator, text mining | PubMed |
| Combined role for YAP-TEAD and YAP-RUNX2 signalling in substrate-stiffness regulation of cardiac fibroblast proliferation. | Biochim Biophys Acta Mol Cell Res | 2022 | 35905788 | PubTator, text mining | PubMed |
| Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial. | Diabetes Care | 2022 | 35894933 | PubTator, text mining | PubMed |
| Conformational Properties and Putative Bioactive Targets for Novel Thiosemicarbazone Derivatives. | Molecules | 2022 | 35889421 | PubTator, text mining | PubMed |
| An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer. | Cancers (Basel) | 2022 | 35884419 | PubTator, text mining | PubMed |
| Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer. | Breast Cancer Res | 2022 | 35850776 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers?page=14